Access to medicines during the COVID-19 pandemic. The role of The Medicines Patent Pool

Greg Martin discusses the Medicines Patent Pool, a global health organization that improves access to essential medicines in low and middle-income countries. The Pool facilitates licensing agreements between patent holders and generic manufacturers, reducing drug prices and increasing availability. The model has proven successful, saving $1.6 billion and supplying 15 billion doses. The Medicines Patent Pool is also addressing COVID-19, ensuring affordable therapeutics reach underserved regions.

In what ways has the Medicines Patent Pool demonstrated its effectiveness?

What role does the Medicines Patent Pool play in the context of the COVID-19 pandemic?